These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30118239)

  • 1. Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection Process.
    Xu A; Kim HS; Estee S; ViaJar S; Galush WJ; Gill A; Hötzel I; Lazar GA; McDonald P; Andersen N; Spiess C
    Mol Pharm; 2018 Oct; 15(10):4529-4537. PubMed ID: 30118239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation.
    Alam ME; Slaney TR; Wu L; Das TK; Kar S; Barnett GV; Leone A; Tessier PM
    J Pharm Sci; 2020 Jan; 109(1):656-669. PubMed ID: 31678251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
    Mehl JT; Sleczka BG; Ciccimaro EF; Kozhich AT; Gilbertson DG; Vuppugalla R; Huang CS; Stevens B; Mo J; Deyanova EG; Wang Y; Huang RY; Chen G; Olah TV
    Bioanalysis; 2016 Aug; 8(15):1611-1622. PubMed ID: 27397670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early engineering approaches to improve peptide developability and manufacturability.
    Furman JL; Chiu M; Hunter MJ
    AAPS J; 2015 Jan; 17(1):111-20. PubMed ID: 25338742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.
    Yan Y; Wei H; Fu Y; Jusuf S; Zeng M; Ludwig R; Krystek SR; Chen G; Tao L; Das TK
    Anal Chem; 2016 Feb; 88(4):2041-50. PubMed ID: 26824491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
    Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
    MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.
    Baek DS; Kim YS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):414-20. PubMed ID: 26036575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody Design and Humanization via In Silico Modeling.
    Kurella VB; Gali R
    Methods Mol Biol; 2018; 1827():3-14. PubMed ID: 30196489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion-pair reversed-phase high performance liquid chromatography method for the quantification of isoaspartic acid in a monoclonal antibody.
    Kern W; Mende R; Denefeld B; Sackewitz M; Chelius D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():26-33. PubMed ID: 24631807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.
    Dion MZ; Leiske D; Sharma VK; Zuch de Zafra CL; Salisbury CM
    Pharm Res; 2018 Oct; 35(11):222. PubMed ID: 30280329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for in silico assessment of Methionine oxidation risk in monoclonal antibodies: Improvement over the 2-shell model.
    Tavella D; Ouellette DR; Garofalo R; Zhu K; Xu J; Oloo EO; Negron C; Ihnat PM
    PLoS One; 2022; 17(12):e0279689. PubMed ID: 36580468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies.
    Yang R; Jain T; Lynaugh H; Nobrega RP; Lu X; Boland T; Burnina I; Sun T; Caffry I; Brown M; Zhi X; Lilov A; Xu Y
    MAbs; 2017; 9(4):646-653. PubMed ID: 28281887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies.
    Satława T; Tarkowski M; Wróbel S; Dudzic P; Gawłowski T; Klaus T; Orłowski M; Kostyn A; Kumar S; Buchanan A; Krawczyk K
    PLoS Comput Biol; 2024 Mar; 20(3):e1011881. PubMed ID: 38442111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N+1 Engineering of an Aspartate Isomerization Hotspot in the Complementarity-Determining Region of a Monoclonal Antibody.
    Patel CN; Bauer SP; Davies J; Durbin JD; Shiyanova TL; Zhang K; Tang JX
    J Pharm Sci; 2016 Feb; 105(2):512-518. PubMed ID: 26869414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants.
    DiCara DM; Andersen N; Chan R; Ernst JA; Ayalon G; Lazar GA; Agard NJ; Hilderbrand A; Hötzel I
    MAbs; 2018 Oct; 10(7):1073-1083. PubMed ID: 30130444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.